InnovAge.be Competitors

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Founded in 1988, the Medicom Group is one of the world’s leading manufacturers and distributors of high-quality infection control, single use and preventive products for the medical, dental, industrial, veterinary, laboratory and health and beauty markets. Based in Montreal, Canada, Medicom has operations in 50 countries, has 10 fully controlled manufacturing plants in North America, Europe and Asia, and sells in over 95 countries. Medicom is committed to making the world a safer and healthier place by using carefully selected materials, cutting-edge technology and continuous innovation to provide protection that healthcare professionals can count on. Fondé en 1988, le groupe Medicom est l'un des leaders mondiaux dans la fabrication et la distribution de produits préventifs à usage unique et de haute qualité pour le contrôle des infections dans les domaines médical, dentaire, industriel, vétérinaire, de laboratoire et de santé et beauté. Basée à Montréal, au Canada, l'entreprise est présente dans 50 pays, possède 8 usines de fabrication entièrement contrôlées en Amérique du Nord, en Europe et en Asie, et vend dans plus de 95 pays. Medicom s'engage à rendre le monde plus sûr et plus sain en utilisant des matériaux soigneusement sélectionnés, une technologie de pointe et une innovation continue pour offrir une protection sur laquelle les professionnels de la santé peuvent compter.

GENESIS Pharma is a European biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products for serious and rare diseases. Established in 1997, GENESIS Pharma was the first pharmaceutical company in Greece and one of the first in Europe to focus on the sales, marketing and distribution of biopharmaceutical products. Shortly after its founding, the company began to steadily expand at a regional level, currently covering 24 countries in Europe. The robust network of its strategic partnerships comprises leading international pharmaceutical companies dedicated to cutting-edge R&D, alongside fast-growing biopharmaceutical companies with pioneering research and disruptive innovations in the development of targeted, specialized treatments for orphan diseases. In total, GENESIS Pharma holds a product portfolio covering over 30 serious and rare diseases.